Drug Type Small molecule drug |
Synonyms Oxprenolol hydrochloride (JP17/USP), BA-39089, Okuspurecol + [4] |
Action antagonists |
Mechanism β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists), β2-adrenergic receptor antagonists(Beta-2 adrenergic receptor antagonists), β3-adrenergic receptor antagonists(Beta-3 adrenergic receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (28 Dec 1983), |
Regulation- |
Molecular FormulaC15H24ClNO3 |
InChIKeyCOAJXCLTPGGDAJ-UHFFFAOYSA-N |
CAS Registry6452-73-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01806 | Oxprenolol Hydrochloride |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Angina Pectoris | United States | 28 Dec 1983 | |
| Anxiety Disorders | United States | 28 Dec 1983 | |
| Arrhythmias, Cardiac | United States | 28 Dec 1983 | |
| Hypertension | United States | 28 Dec 1983 |





